| 1 |
29527530 | Structural and Mechanistic Basis for Extended-Spectrum Drug-Resistance Mutations in Altering the Specificity of TEM, CTX-M, and KPC β-lactamases. | 2018 |
1 |
| 2 |
30501088 | Mutations Utilize Dynamic Allostery to Confer Resistance in TEM-1 β-lactamase. | 2018 Nov 29 |
1 |
| 3 |
27173379 | Shifting Fitness and Epistatic Landscapes Reflect Trade-offs along an Evolutionary Pathway. | 2016 Jul 3 |
1 |
| 4 |
25489790 | Molecular basis for the catalytic specificity of the CTX-M extended-spectrum β-lactamases. | 2015 Jan 20 |
2 |
| 5 |
19736945 | Why the extended-spectrum beta-lactamases SHV-2 and SHV-5 are "hypersusceptible" to mechanism-based inhibitors. | 2009 Oct 20 |
1 |
| 6 |
12183265 | Predicting evolution by in vitro evolution requires determining evolutionary pathways. | 2002 Sep |
1 |
| 7 |
9878443 | The effect of high-frequency random mutagenesis on in vitro protein evolution: a study on TEM-1 beta-lactamase. | 1999 Jan 15 |
3 |
| 8 |
7547898 | Mass spectral kinetic study of acylation and deacylation during the hydrolysis of penicillins and cefotaxime by beta-lactamase TEM-1 and the G238S mutant. | 1995 Sep 19 |
5 |
| 9 |
7785992 | SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients. | 1995 Apr |
1 |
| 10 |
2550326 | Characterization of the plasmid genes blaT-4 and blaT-5 which encode the broad-spectrum beta-lactamases TEM-4 and TEM-5 in enterobacteriaceae. | 1989 May 30 |
1 |